Wed, May 1, 2024

Matt O"Brien Reiterated (TMDX) at Buy with Increased Target to $120 on, May 1st, 2024

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-120-on-may-1st-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Matt O"Brien of Piper Sandler, Reiterated "TransMedics Group, Inc." (TMDX) at Buy with Increased Target from $95 to $120 on, May 1st, 2024.

Matt has made no other calls on TMDX in the last 4 months.

There is 1 other peer that has a rating on TMDX. Out of the 1 peers that are also analyzing TMDX, all agrees with Matt"s Rating of Hold. Following is the relevant analyst calls for the last 4 months;

Cecilia Furlong of "Morgan Stanley" Maintained at Hold with Increased Target to $95 on, Wednesday, February 28th, 2024